VAM
GILD icon

Visionary Asset Management’s Gilead Sciences GILD Stock Holding History

Visionary Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33,558
Closed -$2.59M – 175
2018
Q3 		$2.59M Sell
33,558
-1,427
-4% -$108K 0.83% 44
2018
Q2 		$2.48M Sell
34,985
-4,885
-12% -$345K 0.83% 56
2018
Q1 		$2.94M Sell
39,870
-2,186
-5% -$174K 0.95% 31
2017
Q4 		$3.01M Buy
42,056
+39,356
+1,458% +$2.99M 0.84% 44
2017
Q3 		$219K Buy
+2,700
New +$206K 0.06% 208
2014
Q3 		– Sell
-140
Closed -$12K – 212
2014
Q2 		$12K Buy
+140
New +$10.9K ﹤0.01% 254

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Visionary Asset Management's GILD Position: Q4 2018 in Review

Visionary Asset Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 33,558 shares — an estimated $2.59M sold.

Visionary Asset Management first reported a position in GILD in Q2 2014 and held it in 6 quarters. The position peaked at $3.01M in Q4 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Visionary Asset Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Visionary Asset Management sold 33,558 Gilead Sciences shares in Q4 2018, an estimated $2.59M.
  • Visionary Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 6 quarters.
  • Visionary Asset Management's Gilead Sciences position peaked at $3.01M in Q4 2017.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Visionary Asset Management's 13F filing for Q4 2018, filed 11 Jan 2019.